Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ABBOTT LABORATORIES | 95,696 | reported | 01 Dec 2012 | tx 76+423,775−228,634 |
| Solventum Corp | 3,300 | reported | 15 May 2026 | tx 8+17,791−5,544 |
| AbbVie Inc. | 0 | reported | 16 Nov 2020 | tx 71+1,421,031−1,077,797 |
| SpringWorks Therapeutics, Inc. | 0 | reported | 01 Jul 2025 | tx 11+85,011−85,011 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | GRANT_AWARD | Solventum Corp | 3,300 | 0.00 USD | deriv |
| 27 Mar 2026 | EXERCISE | Solventum Corp | 1,980 | 0.00 USD | |
| 27 Mar 2026 | EXERCISE | Solventum Corp | 1,980 | 0.00 USD | deriv |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 28,861 | — | |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 12,216 | — | deriv |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 13,774 | — | deriv |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 30,160 | — | deriv |
| 13 May 2025 | EXERCISE | Solventum Corp | 3,564 | 0.00 USD | |
| 13 May 2025 | EXERCISE | Solventum Corp | 3,564 | 0.00 USD | deriv |
| 14 May 2025 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 10,060 | 0.00 USD | |
| 30 Apr 2025 | GRANT_AWARD | Solventum Corp | 3,403 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 4,095 | 0.00 USD | |
| 16 May 2024 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 12,216 | 0.00 USD | deriv |
| 13 May 2024 | GRANT_AWARD | Solventum Corp | 3,564 | 0.00 USD | deriv |
| 13 May 2024 | GRANT_AWARD | Solventum Corp | 1,980 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 4,648 | 0.00 USD | |
| 24 May 2023 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 13,774 | 0.00 USD | deriv |
| 14 Jul 2022 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 10,058 | 0.00 USD | |
| 14 Jul 2022 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 30,160 | 0.00 USD | deriv |
| 16 Nov 2020 | EXERCISE | AbbVie Inc. | 115,830 | 35.88 USD | |
| 16 Nov 2020 | SALE | AbbVie Inc. | 115,830 | 100.00 USD | |
| 16 Nov 2020 | EXERCISE | AbbVie Inc. | 115,830 | 0.00 USD | deriv |
| 07 Jul 2020 | SALE | AbbVie Inc. | 30,325 | 100.00 USD | |
| 07 Jul 2020 | SALE | AbbVie Inc. | 23,000 | 100.00 USD | |
| 28 Feb 2020 | TAX_WITHHOLDING | AbbVie Inc. | 32,092 | 85.42 USD |